Cargando…
Recognising Lung Cancer in Primary Care
Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved surv...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318240/ https://www.ncbi.nlm.nih.gov/pubmed/30499068 http://dx.doi.org/10.1007/s12325-018-0843-5 |
_version_ | 1783384836823580672 |
---|---|
author | Bradley, Stephen H. Kennedy, Martyn P. T. Neal, Richard D. |
author_facet | Bradley, Stephen H. Kennedy, Martyn P. T. Neal, Richard D. |
author_sort | Bradley, Stephen H. |
collection | PubMed |
description | Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved survival. Therefore, although recent advances in oncology may herald breakthroughs in effective treatment, achieving early diagnosis will remain crucial to obtaining optimal outcomes. This is challenging, as most lung cancer symptoms are non-specific or are common respiratory symptoms which usually represent benign disease. Identification of patients at risk of lung cancer who require further investigation is an important responsibility for general practitioners (GPs). Diagnosis has historically relied upon plain chest X-ray (CXR), organised in response to symptoms. The sensitivity of this modality, however, compares unfavourably with that of computed tomography (CT). In some jurisdictions screening high-risk individuals with low dose CT (LDCT) is now recommended. However uptake remains low and the eligibility for screening programmes is restricted. Therefore, even if screening is widely adopted, most patients will continue to be diagnosed after presenting with symptoms. Achieving early diagnosis requires GPs to maintain an appropriate level of suspicion and readiness to investigate in high-risk patients or those with non-resolving symptoms. This article discusses the early detection of lung cancer from a primary care perspective. We outline risk factors and epidemiology, the role of screening and offer guidance on the recognition of symptomatic presentation and the investigation and referral of suspected lung cancer. |
format | Online Article Text |
id | pubmed-6318240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-63182402019-01-14 Recognising Lung Cancer in Primary Care Bradley, Stephen H. Kennedy, Martyn P. T. Neal, Richard D. Adv Ther Review Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved survival. Therefore, although recent advances in oncology may herald breakthroughs in effective treatment, achieving early diagnosis will remain crucial to obtaining optimal outcomes. This is challenging, as most lung cancer symptoms are non-specific or are common respiratory symptoms which usually represent benign disease. Identification of patients at risk of lung cancer who require further investigation is an important responsibility for general practitioners (GPs). Diagnosis has historically relied upon plain chest X-ray (CXR), organised in response to symptoms. The sensitivity of this modality, however, compares unfavourably with that of computed tomography (CT). In some jurisdictions screening high-risk individuals with low dose CT (LDCT) is now recommended. However uptake remains low and the eligibility for screening programmes is restricted. Therefore, even if screening is widely adopted, most patients will continue to be diagnosed after presenting with symptoms. Achieving early diagnosis requires GPs to maintain an appropriate level of suspicion and readiness to investigate in high-risk patients or those with non-resolving symptoms. This article discusses the early detection of lung cancer from a primary care perspective. We outline risk factors and epidemiology, the role of screening and offer guidance on the recognition of symptomatic presentation and the investigation and referral of suspected lung cancer. Springer Healthcare 2018-11-29 2019 /pmc/articles/PMC6318240/ /pubmed/30499068 http://dx.doi.org/10.1007/s12325-018-0843-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Bradley, Stephen H. Kennedy, Martyn P. T. Neal, Richard D. Recognising Lung Cancer in Primary Care |
title | Recognising Lung Cancer in Primary Care |
title_full | Recognising Lung Cancer in Primary Care |
title_fullStr | Recognising Lung Cancer in Primary Care |
title_full_unstemmed | Recognising Lung Cancer in Primary Care |
title_short | Recognising Lung Cancer in Primary Care |
title_sort | recognising lung cancer in primary care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318240/ https://www.ncbi.nlm.nih.gov/pubmed/30499068 http://dx.doi.org/10.1007/s12325-018-0843-5 |
work_keys_str_mv | AT bradleystephenh recognisinglungcancerinprimarycare AT kennedymartynpt recognisinglungcancerinprimarycare AT nealrichardd recognisinglungcancerinprimarycare |